Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Lumpectomy Market by Product (Surgical Tools, Lumpectomy Systems) , by End User (Hospitals, Clinics, Ambulatory Surgical Centers) : Global Opportunity Analysis and Industry Forecast, 2024-2033

A03362

Pages: 290

Charts: 54

Tables: 110

Lumpectomy Market Research, 2033

The global lumpectomy market size was valued at $1.7 billion in 2023 and is projected to reach $3.2 billion by 2033, growing at a CAGR of 6.9% from 2024 to 2033.

Market Definition and Overview

Lumpectomy is a surgical procedure to remove a mass (cancerous or non-cancerous) , typically in the breasts, without removing the surrounding healthy breast tissue. Also known as breast-conserving surgery, it aims to remove the tumor while maintaining the natural appearance of the breast. This approach is often preferred over mastectomy for early-stage breast cancer. Lumpectomies are followed by radiation therapy to reduce the risk of cancer recurrence. They offer a balance between effective treatment and preserving breast aesthetics and function, making them a common choice for many patients with small tumors or early-stage breast cancer.

Key Takeaways

  • The lumpectomy industry study covers 20 countries. The research includes a segment analysis of each country in terms of value ($billion) for the projected period from 2024 to 2033.
  • More than 1, 500 product literatures, industry releases, annual reports, and other such documents of major lumpectomy industry participants along with authentic industry journals, trade associations' releases, and government websites have been reviewed for generating high-value industry insights.
  • The study integrates high-quality data, professional opinions and analysis, and critical independent perspectives. The research approach intends to provide a balanced view of global markets and assist stakeholders in making informed decisions in order to achieve their most ambitious growth objectives.

 Key Market Segments

  • By Product
    • Surgical Tools
    • Lumpectomy Systems
  • By End User
    • Hospitals
    • Clinics
    • Ambulatory Surgical Centers
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of LAMEA

 
Key Market Players

  • Dune Medical Devices
  • Hologic, Inc.
  • iCAD
  • Medtronic PLC
  • vector surgical
  • Novian Health, Inc
  • ClearCut Medical
  • Zeiss
  • Sanarus
  • Hologic

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: LUMPECTOMY MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Surgical Tools

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Lumpectomy Systems

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

  • CHAPTER 5: LUMPECTOMY MARKET, BY END USER

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By End User

    • 5.2. Hospitals

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Clinics

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Ambulatory Surgical Centers

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: LUMPECTOMY MARKET, BY REGION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Region

    • 6.2. North America

      • 6.2.1. Key Market Trends and Opportunities

      • 6.2.2. Market Size and Forecast, By Product

      • 6.2.3. Market Size and Forecast, By End User

      • 6.2.4. Market Size and Forecast, By Country

      • 6.2.5. U.S. Lumpectomy Market

        • 6.2.5.1. Market Size and Forecast, By Product
        • 6.2.5.2. Market Size and Forecast, By End User

      • 6.2.6. Canada Lumpectomy Market

        • 6.2.6.1. Market Size and Forecast, By Product
        • 6.2.6.2. Market Size and Forecast, By End User

      • 6.2.7. Mexico Lumpectomy Market

        • 6.2.7.1. Market Size and Forecast, By Product
        • 6.2.7.2. Market Size and Forecast, By End User

    • 6.3. Europe

      • 6.3.1. Key Market Trends and Opportunities

      • 6.3.2. Market Size and Forecast, By Product

      • 6.3.3. Market Size and Forecast, By End User

      • 6.3.4. Market Size and Forecast, By Country

      • 6.3.5. France Lumpectomy Market

        • 6.3.5.1. Market Size and Forecast, By Product
        • 6.3.5.2. Market Size and Forecast, By End User

      • 6.3.6. Germany Lumpectomy Market

        • 6.3.6.1. Market Size and Forecast, By Product
        • 6.3.6.2. Market Size and Forecast, By End User

      • 6.3.7. Italy Lumpectomy Market

        • 6.3.7.1. Market Size and Forecast, By Product
        • 6.3.7.2. Market Size and Forecast, By End User

      • 6.3.8. Spain Lumpectomy Market

        • 6.3.8.1. Market Size and Forecast, By Product
        • 6.3.8.2. Market Size and Forecast, By End User

      • 6.3.9. UK Lumpectomy Market

        • 6.3.9.1. Market Size and Forecast, By Product
        • 6.3.9.2. Market Size and Forecast, By End User

      • 6.3.10. Russia Lumpectomy Market

        • 6.3.10.1. Market Size and Forecast, By Product
        • 6.3.10.2. Market Size and Forecast, By End User

      • 6.3.11. Rest Of Europe Lumpectomy Market

        • 6.3.11.1. Market Size and Forecast, By Product
        • 6.3.11.2. Market Size and Forecast, By End User

    • 6.4. Asia-Pacific

      • 6.4.1. Key Market Trends and Opportunities

      • 6.4.2. Market Size and Forecast, By Product

      • 6.4.3. Market Size and Forecast, By End User

      • 6.4.4. Market Size and Forecast, By Country

      • 6.4.5. China Lumpectomy Market

        • 6.4.5.1. Market Size and Forecast, By Product
        • 6.4.5.2. Market Size and Forecast, By End User

      • 6.4.6. Japan Lumpectomy Market

        • 6.4.6.1. Market Size and Forecast, By Product
        • 6.4.6.2. Market Size and Forecast, By End User

      • 6.4.7. India Lumpectomy Market

        • 6.4.7.1. Market Size and Forecast, By Product
        • 6.4.7.2. Market Size and Forecast, By End User

      • 6.4.8. South Korea Lumpectomy Market

        • 6.4.8.1. Market Size and Forecast, By Product
        • 6.4.8.2. Market Size and Forecast, By End User

      • 6.4.9. Australia Lumpectomy Market

        • 6.4.9.1. Market Size and Forecast, By Product
        • 6.4.9.2. Market Size and Forecast, By End User

      • 6.4.10. Thailand Lumpectomy Market

        • 6.4.10.1. Market Size and Forecast, By Product
        • 6.4.10.2. Market Size and Forecast, By End User

      • 6.4.11. Malaysia Lumpectomy Market

        • 6.4.11.1. Market Size and Forecast, By Product
        • 6.4.11.2. Market Size and Forecast, By End User

      • 6.4.12. Indonesia Lumpectomy Market

        • 6.4.12.1. Market Size and Forecast, By Product
        • 6.4.12.2. Market Size and Forecast, By End User

      • 6.4.13. Rest of Asia Pacific Lumpectomy Market

        • 6.4.13.1. Market Size and Forecast, By Product
        • 6.4.13.2. Market Size and Forecast, By End User

    • 6.5. LAMEA

      • 6.5.1. Key Market Trends and Opportunities

      • 6.5.2. Market Size and Forecast, By Product

      • 6.5.3. Market Size and Forecast, By End User

      • 6.5.4. Market Size and Forecast, By Country

      • 6.5.5. Brazil Lumpectomy Market

        • 6.5.5.1. Market Size and Forecast, By Product
        • 6.5.5.2. Market Size and Forecast, By End User

      • 6.5.6. South Africa Lumpectomy Market

        • 6.5.6.1. Market Size and Forecast, By Product
        • 6.5.6.2. Market Size and Forecast, By End User

      • 6.5.7. Saudi Arabia Lumpectomy Market

        • 6.5.7.1. Market Size and Forecast, By Product
        • 6.5.7.2. Market Size and Forecast, By End User

      • 6.5.8. UAE Lumpectomy Market

        • 6.5.8.1. Market Size and Forecast, By Product
        • 6.5.8.2. Market Size and Forecast, By End User

      • 6.5.9. Argentina Lumpectomy Market

        • 6.5.9.1. Market Size and Forecast, By Product
        • 6.5.9.2. Market Size and Forecast, By End User

      • 6.5.10. Rest of LAMEA Lumpectomy Market

        • 6.5.10.1. Market Size and Forecast, By Product
        • 6.5.10.2. Market Size and Forecast, By End User

  • CHAPTER 7: COMPETITIVE LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top Winning Strategies

    • 7.3. Product Mapping Of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Top Player Positioning, 2024

  • CHAPTER 8: COMPANY PROFILES

    • 8.1. Vector Surgical

      • 8.1.1. Company Overview

      • 8.1.2. Key Executives

      • 8.1.3. Company Snapshot

      • 8.1.4. Operating Business Segments

      • 8.1.5. Product Portfolio

      • 8.1.6. Business Performance

      • 8.1.7. Key Strategic Moves and Developments

    • 8.2. Novian Health, Inc

      • 8.2.1. Company Overview

      • 8.2.2. Key Executives

      • 8.2.3. Company Snapshot

      • 8.2.4. Operating Business Segments

      • 8.2.5. Product Portfolio

      • 8.2.6. Business Performance

      • 8.2.7. Key Strategic Moves and Developments

    • 8.3. ClearCut Medical

      • 8.3.1. Company Overview

      • 8.3.2. Key Executives

      • 8.3.3. Company Snapshot

      • 8.3.4. Operating Business Segments

      • 8.3.5. Product Portfolio

      • 8.3.6. Business Performance

      • 8.3.7. Key Strategic Moves and Developments

    • 8.4. Dune Medical Devices

      • 8.4.1. Company Overview

      • 8.4.2. Key Executives

      • 8.4.3. Company Snapshot

      • 8.4.4. Operating Business Segments

      • 8.4.5. Product Portfolio

      • 8.4.6. Business Performance

      • 8.4.7. Key Strategic Moves and Developments

    • 8.5. Sanarus

      • 8.5.1. Company Overview

      • 8.5.2. Key Executives

      • 8.5.3. Company Snapshot

      • 8.5.4. Operating Business Segments

      • 8.5.5. Product Portfolio

      • 8.5.6. Business Performance

      • 8.5.7. Key Strategic Moves and Developments

    • 8.6. ICAD

      • 8.6.1. Company Overview

      • 8.6.2. Key Executives

      • 8.6.3. Company Snapshot

      • 8.6.4. Operating Business Segments

      • 8.6.5. Product Portfolio

      • 8.6.6. Business Performance

      • 8.6.7. Key Strategic Moves and Developments

    • 8.7. Hologic, Inc.

      • 8.7.1. Company Overview

      • 8.7.2. Key Executives

      • 8.7.3. Company Snapshot

      • 8.7.4. Operating Business Segments

      • 8.7.5. Product Portfolio

      • 8.7.6. Business Performance

      • 8.7.7. Key Strategic Moves and Developments

    • 8.8. Medtronic PLC

      • 8.8.1. Company Overview

      • 8.8.2. Key Executives

      • 8.8.3. Company Snapshot

      • 8.8.4. Operating Business Segments

      • 8.8.5. Product Portfolio

      • 8.8.6. Business Performance

      • 8.8.7. Key Strategic Moves and Developments

    • 8.9. Hologic

      • 8.9.1. Company Overview

      • 8.9.2. Key Executives

      • 8.9.3. Company Snapshot

      • 8.9.4. Operating Business Segments

      • 8.9.5. Product Portfolio

      • 8.9.6. Business Performance

      • 8.9.7. Key Strategic Moves and Developments

    • 8.10. Zeiss

      • 8.10.1. Company Overview

      • 8.10.2. Key Executives

      • 8.10.3. Company Snapshot

      • 8.10.4. Operating Business Segments

      • 8.10.5. Product Portfolio

      • 8.10.6. Business Performance

      • 8.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL LUMPECTOMY MARKET, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL LUMPECTOMY MARKET FOR SURGICAL TOOLS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL LUMPECTOMY MARKET FOR LUMPECTOMY SYSTEMS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL LUMPECTOMY MARKET, BY END USER, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL LUMPECTOMY MARKET FOR HOSPITALS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL LUMPECTOMY MARKET FOR CLINICS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL LUMPECTOMY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL LUMPECTOMY MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. NORTH AMERICA LUMPECTOMY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. NORTH AMERICA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 11. NORTH AMERICA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 12. U.S. LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 13. U.S. LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 14. CANADA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 15. CANADA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 16. MEXICO LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 17. MEXICO LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 18. EUROPE LUMPECTOMY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. EUROPE LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 20. EUROPE LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 21. FRANCE LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 22. FRANCE LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 23. GERMANY LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 24. GERMANY LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 25. ITALY LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 26. ITALY LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 27. SPAIN LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 28. SPAIN LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 29. UK LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 30. UK LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 31. RUSSIA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 32. RUSSIA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 33. REST OF EUROPE LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 34. REST OF EUROPE LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 35. ASIA-PACIFIC LUMPECTOMY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 36. ASIA-PACIFIC LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 37. ASIA-PACIFIC LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 38. CHINA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 39. CHINA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 40. JAPAN LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 41. JAPAN LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 42. INDIA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 43. INDIA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 44. SOUTH KOREA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 45. SOUTH KOREA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 46. AUSTRALIA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 47. AUSTRALIA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 48. THAILAND LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 49. THAILAND LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 50. MALAYSIA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 51. MALAYSIA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 52. INDONESIA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 53. INDONESIA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 54. REST OF ASIA PACIFIC LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 55. REST OF ASIA PACIFIC LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 56. LAMEA LUMPECTOMY, BY REGION, 2025-2033 ($MILLION)
  • TABLE 57. LAMEA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 58. LAMEA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 59. BRAZIL LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 60. BRAZIL LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 61. SOUTH AFRICA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 62. SOUTH AFRICA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 63. SAUDI ARABIA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 64. SAUDI ARABIA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 65. UAE LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 66. UAE LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 67. ARGENTINA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 68. ARGENTINA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 69. REST OF LAMEA LUMPECTOMY, BY PRODUCT, 2025-2033 ($MILLION)
  • TABLE 70. REST OF LAMEA LUMPECTOMY, BY END USER, 2025-2033 ($MILLION)
  • TABLE 71. VECTOR SURGICAL: KEY EXECUTIVES
  • TABLE 72. VECTOR SURGICAL: COMPANY SNAPSHOT
  • TABLE 73. VECTOR SURGICAL: OPERATING SEGMENTS
  • TABLE 74. VECTOR SURGICAL: PRODUCT PORTFOLIO
  • TABLE 75. VECTOR SURGICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 76. NOVIAN HEALTH, INC: KEY EXECUTIVES
  • TABLE 77. NOVIAN HEALTH, INC: COMPANY SNAPSHOT
  • TABLE 78. NOVIAN HEALTH, INC: OPERATING SEGMENTS
  • TABLE 79. NOVIAN HEALTH, INC: PRODUCT PORTFOLIO
  • TABLE 80. NOVIAN HEALTH, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 81. CLEARCUT MEDICAL: KEY EXECUTIVES
  • TABLE 82. CLEARCUT MEDICAL: COMPANY SNAPSHOT
  • TABLE 83. CLEARCUT MEDICAL: OPERATING SEGMENTS
  • TABLE 84. CLEARCUT MEDICAL: PRODUCT PORTFOLIO
  • TABLE 85. CLEARCUT MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 86. DUNE MEDICAL DEVICES: KEY EXECUTIVES
  • TABLE 87. DUNE MEDICAL DEVICES: COMPANY SNAPSHOT
  • TABLE 88. DUNE MEDICAL DEVICES: OPERATING SEGMENTS
  • TABLE 89. DUNE MEDICAL DEVICES: PRODUCT PORTFOLIO
  • TABLE 90. DUNE MEDICAL DEVICES: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 91. SANARUS: KEY EXECUTIVES
  • TABLE 92. SANARUS: COMPANY SNAPSHOT
  • TABLE 93. SANARUS: OPERATING SEGMENTS
  • TABLE 94. SANARUS: PRODUCT PORTFOLIO
  • TABLE 95. SANARUS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 96. ICAD: KEY EXECUTIVES
  • TABLE 97. ICAD: COMPANY SNAPSHOT
  • TABLE 98. ICAD: OPERATING SEGMENTS
  • TABLE 99. ICAD: PRODUCT PORTFOLIO
  • TABLE 100. ICAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 101. HOLOGIC, INC.: KEY EXECUTIVES
  • TABLE 102. HOLOGIC, INC.: COMPANY SNAPSHOT
  • TABLE 103. HOLOGIC, INC.: OPERATING SEGMENTS
  • TABLE 104. HOLOGIC, INC.: PRODUCT PORTFOLIO
  • TABLE 105. HOLOGIC, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 106. MEDTRONIC PLC: KEY EXECUTIVES
  • TABLE 107. MEDTRONIC PLC: COMPANY SNAPSHOT
  • TABLE 108. MEDTRONIC PLC: OPERATING SEGMENTS
  • TABLE 109. MEDTRONIC PLC: PRODUCT PORTFOLIO
  • TABLE 110. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 111. HOLOGIC: KEY EXECUTIVES
  • TABLE 112. HOLOGIC: COMPANY SNAPSHOT
  • TABLE 113. HOLOGIC: OPERATING SEGMENTS
  • TABLE 114. HOLOGIC: PRODUCT PORTFOLIO
  • TABLE 115. HOLOGIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 116. ZEISS: KEY EXECUTIVES
  • TABLE 117. ZEISS: COMPANY SNAPSHOT
  • TABLE 118. ZEISS: OPERATING SEGMENTS
  • TABLE 119. ZEISS: PRODUCT PORTFOLIO
  • TABLE 120. ZEISS: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL LUMPECTOMY MARKET SEGMENTATION
  • FIGURE 2. GLOBAL LUMPECTOMY MARKET
  • FIGURE 3. SEGMENTATION LUMPECTOMY MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN LUMPECTOMY MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALLUMPECTOMY MARKET
  • FIGURE 11. LUMPECTOMY MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. LUMPECTOMY MARKET FOR SURGICAL TOOLS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. LUMPECTOMY MARKET FOR LUMPECTOMY SYSTEMS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. LUMPECTOMY MARKET SEGMENTATION, BY BY END USER
  • FIGURE 15. LUMPECTOMY MARKET FOR HOSPITALS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. LUMPECTOMY MARKET FOR CLINICS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 17. LUMPECTOMY MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 19. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 20. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 21. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 22. COMPETITIVE DASHBOARD
  • FIGURE 23. COMPETITIVE HEATMAP: LUMPECTOMY MARKET
  • FIGURE 24. TOP PLAYER POSITIONING, 2024
  • FIGURE 25. VECTOR SURGICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 26. VECTOR SURGICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 27. VECTOR SURGICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 28. NOVIAN HEALTH, INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 29. NOVIAN HEALTH, INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 30. NOVIAN HEALTH, INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 31. CLEARCUT MEDICAL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 32. CLEARCUT MEDICAL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 33. CLEARCUT MEDICAL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 34. DUNE MEDICAL DEVICES: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. DUNE MEDICAL DEVICES: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. DUNE MEDICAL DEVICES: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. SANARUS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. SANARUS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. SANARUS: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. ICAD: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. ICAD: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. ICAD: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. HOLOGIC, INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. HOLOGIC, INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. HOLOGIC, INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. MEDTRONIC PLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. MEDTRONIC PLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. MEDTRONIC PLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. HOLOGIC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. HOLOGIC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. HOLOGIC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. ZEISS: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. ZEISS: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. ZEISS: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Lumpectomy Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved